Psychemedics Corporation Announces Q4 and Year End Results
Mar 07, 2018 22:00 pm UTC| Business
ACTON, Mass., March 07, 2018 -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2017. The Company also announced a quarterly...
Mar 07, 2018 21:45 pm UTC| Business
MONTREAL, March 07, 2018 -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today presented new results from additional analyses based on studies conducted with Trogarzo™ and EGRIFTA®. The study conclusions were...
ERS Signs Agreement With Companies Registry Office in Ireland to Deliver New Registry Technology
Mar 07, 2018 21:35 pm UTC| Business
REGINA, Saskatchewan , March 07, 2018 -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) is pleased to announce that its wholly owned Irish subsidiary, Enterprise Registry Solutions Ltd. (“ERS”), has...
KKR to Acquire Majority Interest in Heartland Dental
Mar 07, 2018 21:32 pm UTC| Business
Effingham, Ill., March 07, 2018 -- Heartland Dental, the largest dental support organization in the United States, today announced that it has entered into a definitive agreement whereby KKR will acquire a majority...
Mar 07, 2018 21:31 pm UTC| Business
NEW YORK, March 07, 2018 -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reviewed progress being made under the new Win StrategyTM and provided an update to its...
tronc, Inc. Reports Fourth Quarter and Full Year 2017 Results
Mar 07, 2018 21:31 pm UTC| Business
CHICAGO, March 07, 2018 -- tronc, Inc. (NASDAQ:TRNC) today announced financial results for the fourth quarter and full year ended December 31, 2017. Please note, the Company’s fiscal year 2017 consisted of 53 weeks...
CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
Mar 07, 2018 21:31 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 07, 2018 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today...